5 May 2016

Cancer society expects melanoma drug Opdivo to be approved

From Morning Report, 8:29 am on 5 May 2016

Many say yesterday's announcement was primarily in response to public pressure over new generation melanoma drugs. Pharmac yesterday announced funding for Opdivo, an advanced melanoma drug in the same class as Keytruda.